BRCA1-Mediated Inflammation and Growth Activated & Inhibited Transition Mechanisms Between No-Tumor Hepatitis/Cirrhotic Tissues and HCC

BRCA1Related Inflammation-Growth Transition

descriptionPublicationkeyboard_double_arrow_right Article 23 Jan 2014 English Publisher:WileyJournal:Journal of Cellular Biochemistry, volume 115, pages 641-650 (issn: 0730-2312,

Authors: Haizhen Diao; Lin Wang; Juxiang Huang; Minghu Jiang; Huilei Zhou; Xiaohe Li; Qingchun Chen; +2 Authors

doi: 10.1002/jcb.24699

BRCA1-Mediated Inflammation and Growth Activated & Inhibited Transition Mechanisms Between No-Tumor Hepatitis/Cirrhotic Tissues and HCC

- Summary
- Related research
  (10)
- Metrics

tips_and_updates
Recommended

Related Organizations

Beijing University of Posts and Telecommunications
China (People's Republic of)
Tsinghua University
China (People's Republic of)
China University of Mining and Technology
China (People's Republic of)
State Key Laboratory of Drug Research
China (People's Republic of)
Chinese Academy of Sciences
China (People's Republic of)

View all View all

10 Research products, page 1 of 1

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	4
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

BRCA1-Mediated Inflammation and Growth Activated & Inhibited Transition Mechanisms Between No-Tumor Hepatitis/Cirrhotic Tissues and HCC

BRCA1-Mediated Inflammation and Growth Activated & Inhibited Transition Mechanisms Between No-Tumor Hepatitis/Cirrhotic Tissues and HCC

10 Research products, page 1 of 1

Parathyroid Hormone-Like Hormone (PTHLH) Feedback Mitosis to Downstream DNA Replication Coupling Postreplication Repair-Induced Cell Proliferation Network in No-Tumor Hepatitis/Cirrhotic Tissues (HBV or HCV Infection) by Systems-Theoretical Analysis

Tissue-specific transplantation antigen P35B (TSTA3) immune response–mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation

PTHLHcoupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis

ActivatedPTHLHCoupling Feedback Phosphoinositide to G-Protein Receptor Signal-Induced Cell Adhesion Network in Human Hepatocellular Carcinoma by Systems-Theoretic Analysis

ALK Folic Acid Transport and Integrin Signal Induced-Angiogenesis Network in Human Hepatocellular Carcinoma (HCC) by Systems-Theoretical Analysis

Inhibited PTHLH downstream leukocyte adhesion-mediated protein amino acid N-linked glycosylation coupling Notch and JAK–STAT cascade to iron–sulfur cluster assembly-induced aging network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by systems-theoretical analysis

Cytosolic Iron-Sulfur Protein Assembly 1 (CIAO1) Downstream Activation of Phospholipase A2 and Hormone-Mediated Signaling-Induced Cell Death Network in Human Hepatocellular Carcinoma (HCC) by Systems- Theoretical Analysis

AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues

BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.

<i>RRM2</i> Computational Phosphoprotein Network Construction and Analysis between No-Tumor Hepatitis/Cirrhotic Liver Tissues and Human Hepatocellular Carcinoma (HCC)